Hims & Hers Health reported Q4 2024 revenue of $481.1M, missed analyst consensus of $494.6M by $13.4M. Diluted EPS came in at $0.11, beat the $0.09 consensus by $0.02.
Trailing eight quarters through Q4 2024
Common questions about Hims & Hers Health's Q4 2024 earnings report.
Hims & Hers Health (HIMS) reported Q4 2024 earnings on February 24, 2025 after market close.
Hims & Hers Health reported revenue of $481.1M and diluted EPS of $0.11 for Q4 2024.
Revenue missed the consensus estimate of $494.6M by $13.4M. EPS beat the consensus estimate of $0.09 by $0.02.
You can read the 10-K periodic report (0001773751-25-000062) directly on SEC EDGAR. The filing index links above go to sec.gov.